Question

Difficulty: HardOrdering Laboratory Tests

For each of the following patients presenting with clinical and biochemical evidence of hepatic injury, select the most appropriate confirmatory or highly specific diagnostic laboratory evaluation.

  • A 34-year-old man presents with progressive resting tremor, dysarthria, and behavioral changes. Hepatic panel reveals an aspartate aminotransferase of 85 U/L and an alanine aminotransferase of 92 U/L.Serum ceruloplasmin level and 24-hour urinary copper excretion
  • A 51-year-old woman describes three months of debilitating fatigue and severe generalized pruritus. Her alkaline phosphatase is 410 U/L with normal transaminases. Abdominal ultrasound shows no biliary dilation.Antimitochondrial antibody (AMA) titer
  • A 29-year-old primigravida at 34 weeks gestation develops intense nighttime itching predominantly on her palms and soles. Laboratory testing shows mildly elevated transaminases with a normal gamma-glutamyl transferase.Fasting serum total bile acid concentration
  • A 45-year-old man with type 2 diabetes mellitus presents with new-onset symmetric arthralgias in his second and third metacarpophalangeal joints. Hepatic panel reveals an alanine aminotransferase of 115 U/L.Serum transferrin saturation and ferritin levels
  • A 38-year-old woman with a history of hypothyroidism presents with acute-onset jaundice and fatigue. Laboratory evaluation shows an aspartate aminotransferase of 580 U/L, alanine aminotransferase of 640 U/L, and hypergammaglobulinemia.Anti-smooth muscle antibody and anti-liver/kidney microsomal type 1 antibody assays

Answer

Each patient's unique demographic profile, symptom cluster, and initial hepatic panel pattern dictates a highly specific targeted laboratory evaluation: copper studies for Wilson disease, AMA for primary biliary cholangitis, bile acids for intrahepatic cholestasis of pregnancy, iron studies for hemochromatosis, and ASMA/anti-LKM1 for autoimmune hepatitis.
Each clinical scenario provides cardinal demographic features, extrahepatic manifestations, and initial biochemical patterns (hepatocellular vs. cholestatic) that narrow the differential diagnosis to a single leading etiology. Selecting the precise targeted laboratory test prevents unnecessary invasive procedures, limits diagnostic cost, and expedites definitive management.

Step-by-Step Solution

1
Analyze the 34-year-old man's presentation.
Identify that early-onset neuropsychiatric symptoms paired with transaminitis suggest copper deposition in the basal ganglia and liver, indicating Wilson disease.
Requires targeted testing with serum ceruloplasmin and 24-hour urinary copper.
2
Evaluate the 51-year-old woman's isolated alkaline phosphatase elevation.
Recognize the classic demographic (middle-aged female) and cholestatic laboratory pattern without ductal dilation as primary biliary cholangitis.
Dictates ordering an antimitochondrial antibody (AMA) titer for confirmation.
3
Assess the pregnant patient's palmar/plantar pruritus.
Diagnose likely intrahepatic cholestasis of pregnancy given the trimester, symptom location, and normal GGT.
Requires establishing the diagnosis biochemically via fasting serum total bile acid concentration.
4
Correlate the 45-year-old man's diabetes and MCP arthropathy.
Identify this specific symptom cluster alongside liver inflammation as highly suspicious for iron overload (hereditary hemochromatosis).
Necessitates screening with serum transferrin saturation and ferritin levels.
5
Synthesize the 38-year-old woman's marked hepatocellular injury and hypergammaglobulinemia.
Recognize the autoimmune diathesis (hypothyroidism) and >500 U/L transaminases as indicative of autoimmune hepatitis.
Prompts ordering anti-smooth muscle antibody and anti-LKM1 assays.

Key Concept

Targeted Diagnostic Laboratory Sequencing for Hepatic Pathology
Estimated Time:2m 0s
Rate this question